Vortioxetine disposition in obesity: potential implications for patient safety

DJ Greenblatt, JS Harmatz… - Journal of Clinical …, 2018 - journals.lww.com
Background Obesity and depression are common comorbid conditions. The objective of the
study was to evaluate the effect of obesity on the pharmacokinetics of the serotonergic …
被引用次数：19 相关文章

Vortioxetine Disposition in Obesity: Potential Implications for Patient Safety

DJ Greenblatt, JS Harmatz… - Journal of clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Obesity and depression are common comorbid conditions. The objective of the
study was to evaluate the effect of obesity on the pharmacokinetics of the serotonergic …

Vortioxetine Disposition in Obesity: Potential Implications for Patient Safety.

DJ Greenblatt, JS Harmatz, CR Chow - Journal of Clinical …, 2018 - europepmc.org
Background Obesity and depression are common comorbid conditions. The objective of the
study was to evaluate the effect of obesity on the pharmacokinetics of the serotonergic …

Vortioxetine disposition in obesity: potential implications for patient safety.

DJ Greenblatt, JS Harmatz, CR Chow - 2018 - cabidigitallibrary.org
Background: Obesity and depression are common comorbid conditions. The objective of the
study was to evaluate the effect of obesity on the pharmacokinetics of the serotonergic …